Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma

NCT05105100 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT05105100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05105100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma
Lead sponsor
University of California, San Francisco
Phase
Observational
Overall status
Completed
Start date
October 29, 2021
Completion date
September 15, 2025
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced melanoma, melanoma